ACADIA PHARMACEUTICALS INC (ACAD) Net income 2016–2025
ACADIA PHARMACEUTICALS INC (ACAD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$391.0MFY2025 · since FY2016: -$271.4M → $391.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $391.0M | +73.0% |
| FY2024 | $226.0M | +470.5% |
| FY2023 | -$61.0M | +71.5% |
| FY2022 | -$214.0M | -27.4% |
| FY2021 | -$168.0M | +40.3% |
| FY2020 | -$281.6M | -19.7% |
| FY2019 | -$235.3M | +4.1% |
| FY2018 | -$245.2M | +15.3% |
| FY2017 | -$289.4M | -6.6% |
| FY2016 | -$271.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice